BIOQ. Bioqual Inc.

John C. Landon, Founder of BIOQUAL, Inc., Passes Away at the Age Of 84

Dr. John C. Landon, past president, CEO and former chairman of the board of BIOQUAL, passed away Sunday, January 10, 2021, at the age of 84. John was born and raised in Hornell, New York, and went on to earn a B.A. degree in biology from Alfred College (class of 1959) and M.S. and Ph.D. degrees in biology from The George Washington University in 1962 and 1967, respectively. John worked for most of his career in Maryland, but spent his summers in Brewster, Massachusetts, which he retired to in 2013.

John had a long and distinguished career in biology. He began his career at the National Cancer Institute working in cancer virology, then went on to join Litton Bionetics from 1965 until 1975, where he became the Science Director of the Frederick Cancer Research Center. In 1975, he became President and Director of Mason Research Institute, a subsidiary of Edgerton, Germeshausen, and Grier, Inc., now known as Perkin Elmer. In 1982, he became president of BIOQUAL, originally named Diagnon Corporation, a biomedical research corporation that provided contract services to the National Institutes of Health, as well as academic and commercial clients. He led BIOQUAL for more than 30 years as President and CEO, and was a key figure in its growth and development from a one-product company to a $20M + life sciences corporation by the time of his retirement. BIOQUAL continues to thrive today, providing innovative research support for improved global health and playing a key role in testing vaccines and therapeutics for COVID-19 and many other diseases.

EN
22/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioqual Inc.

 PRESS RELEASE

BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fis...

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc. (OTC Pink: BIOQ) : Six Months Ended   Three Months Ended November 30,   November 30,   2024       2023       2024       2023   Revenue $ 23,165,920   $ 31,448,326 $ 11,395,438   $ 15,869,404 (Loss) Income Before Income Tax $ (2,604,227 ) $ 1,909,744   $ (1,672,402 ) ...

 PRESS RELEASE

BIOQUAL Announces Changes to Board of Directors

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc. BIOQ(Pinksheets) BIOQUAL, Inc., announced today that Mr. Charles Francisco retired from his role as a BIOQUAL Board Member effective December 31, 2024. Mr. Francisco is 85 years old and has served as a director since 1992. His retirement is not connected to any disagreements with the Board’s policies or practices. Additionally, on December 31, 2024 BIOQUAL welcomed Ms. Amy Johnston to the BIOQUAL Board of Directors. Ms. Johnston will replace Mr. Francisco on the Board, thus, the number of directors will not change. Ms. Johnston has been work...

 PRESS RELEASE

BIOQUAL Presents Unaudited Financial Results for First Quarter of Fisc...

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc. (OTC Pink: BIOQ) :   Three Months Ended August 31,       2024     2023 Revenue  $ 11,770,482   $ 15,578,922   Income (Loss) Before Income Tax  $ (931,825 ) $ 1,241,183   Net Income (Loss)  $ (675,325 ) $ 899,483   Basic Earnings per Share of Common Stock  $  (0.76 ) $ 1.01   Diluted Earnings per Share of Common Stock   $  (0.76 ) $ 1.01   Weighted Average   Number of Sha...

 PRESS RELEASE

BIOQUAL Declares Dividend

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL’s Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 7, 2024, payable on October 28, 2024. This is the twenty-third dividend declared by BIOQUAL. Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which ...

 PRESS RELEASE

BIOQUAL Presents Financial Results for Fiscal Year 2024

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc. (OTC Pink: BIOQ) :     2024 2023   Revenue $ 58,590,949 $ 62,663,804   Income Before Income Tax $ 476,447 $ 1,133,242   Net Income $ 483,481 $ 835,548   Basic Earnings per Share of Common Stock $ .54 $ .93   Diluted Earnings per Share of Common Stock $ .54 $ .93   Weighted Average     Number of Shares Outstanding     For Basic Earnings Per Share   894,416   8...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch